Related Experiment Video
Updated: Jul 24, 2025

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.6K
Comparison of cancer subtype identification methods combined with feature selection methods in omics data analysis
JiYoon Park1, Jae Won Lee1, Mira Park2
1Department of Statistics, Korea University, 145 Anam-Ro, Seongbuk-Gu, Seoul, 02841, South Korea.
Biodata Mining
|July 7, 2023
Summary
Choosing the best cancer subtyping method depends on the data and evaluation metrics. This study compared various feature selection and subtype identification combinations to guide optimal strategy selection for cancer research.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Accurate cancer subtype identification is crucial for effective diagnosis and treatment.
- Feature selection is vital for reducing data dimensionality and identifying informative genes for cancer subtyping.
- Combinatorial approaches integrating feature selection and subtype identification methods are underexplored.
Purpose of the Study:
- To identify the optimal combination of feature selection and subtype identification methods for single omics data analysis.
- To evaluate the performance of various feature selection techniques when combined with unsupervised clustering algorithms.
- To provide a guideline for selecting the best methodology based on data characteristics and evaluation criteria.
Main Methods:
- Investigated combinations of six filter-based feature selection methods and six unsupervised subtype identification algorithms.
- Utilized The Cancer Genome Atlas (TCGA) datasets across four cancer types for comprehensive analysis.
- Evaluated method performance using multiple metrics, focusing on p-values and accuracy.
Main Results:
- No single combination consistently outperformed others across all datasets and metrics.
- Consensus Clustering (CC) and Neighborhood-Based Multi-omics Clustering (NEMO) with variance-based feature selection showed promising results (lower p-values).
- Nonnegative Matrix Factorization (NMF) demonstrated improved performance with feature selection, particularly when combined with Similarity Network Fusion (SNF), Monte Carlo Feature Selection (MCFS), and Minimum-Redundancy Maximum Relevance (mRMR).
Conclusions:
- The optimal combination of methods is context-dependent, varying with data type, feature set size, and chosen evaluation metrics.
- A practical guideline is proposed to aid researchers in selecting the most appropriate method combination for their specific cancer subtyping tasks.
- This study highlights the importance of synergistic feature selection and subtype identification strategies in cancer omics data analysis.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
397
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
397

